TH
INSIDER · HALO · HALOZYME THERAPEUTICS, INC. · PRESIDENT AND CEO
Torley Helen
Every open-market transaction filed under this name, Sep 9 to Sep 11.
Filings
7
0 buys · 7 sells
Bought
—
open market, at cost
Sold
$6.4M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 11 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 4,508 | $107.55 | $485K | — |
| Sep 11 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 15,492 | $107.15 | $1.7M | — |
| Sep 10 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 5,412 | $107.58 | $582K | — |
| Sep 10 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 14,588 | $107.01 | $1.6M | — |
| Sep 9 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 100 | $108.67 | $11K | — |
| Sep 9 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 6,596 | $107.82 | $711K | — |
| Sep 9 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 13,304 | $107.22 | $1.4M | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.